Swing of the pendulum: Optimizing functional outcomes in larynx cancer

Current Oncology Reports

Volumn 10, Issue 2, 2008, Pages 170-175

  Holsinger, F Christopher ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CISPLATIN; ERLOTINIB; FLUOROURACIL; GEFITINIB; PLATINUM COMPLEX;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REHABILITATION; CANCER SURVIVAL; CLINICAL TRIAL; CONSERVATIVE TREATMENT; FUNCTIONAL ASSESSMENT; HEAD AND NECK SURGERY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LARYNGECTOMY; LARYNX CANCER; LIFE EXPECTANCY; MINIMALLY INVASIVE SURGERY; MOLECULAR THERAPY; MULTIMODALITY CANCER THERAPY; ORGAN PRESERVATION; QUALITY OF LIFE; REVIEW; ROBOTICS; SURGICAL APPROACH; TREATMENT OUTCOME; TREATMENT PLANNING;

COMBINED MODALITY THERAPY; HUMANS; LARYNGEAL NEOPLASMS; LARYNX; MEDICAL ONCOLOGY; QUALITY OF LIFE; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 40849113228     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-008-0026-7     Document Type: Review

References (42)

1. The Department of Veterans Affairs Laryngeal Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991, 324:1685-1690.
2. Forastiere AA, Goepfert H, Maor M, et al.: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003, 349:2091-2098.
3. Pignon JP, Bourhis J, Domenge C, Designé L: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000, 355:949-955.
4. Bourhis J, Amand C, Pignon JP; MACH-NC Collaborative Group: Update of MACH-NC (Meta-Analysis of Chemotherapy in Head and Neck Cancer) database focused on concomitant chemotherapy [ASCO abstract]. J Clin Oncol 2004, 22(14S):abstract 5505.
5. National Comprehensive Cancer Center Network: Clinical practice guidelines in oncology - v.1.2007: head and neck cancer. http://www.nccn.org/professionals/physician_gls/PDF/head-and-neck.pdf. Accessed December 2007.
6. Pfister DG, Laurie SA, Weinstein GS, et al.: American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006, 24:3693-3704.
7. Rosenthal DI, Lewin JS, Eisbruch A: Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 2006, 24:2636-2643.
8. Kotz T, Costello R, Li Y, Posner MR: Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck 2004, 26:365-372.
9. Rademaker AW, Vonesh EF, Logemann JA, et al.: Eating ability in head and neck cancer patients after treatment with chemoradiation: a 12-month follow-up study accounting for dropout. Head Neck 2003, 25:1034-1041.
10. Roh JL, Kim AY, Cho MJ: Xerostomia following radiotherapy of the head and neck. J Clin Oncol 2005, 23:3016-3023.
11. Campbell BH, Spinelly K, Marbella AM, et al.: Aspiration, weight loss, and quality of life in head and neck survivors. Arch Otolaryngol Head Neck Surg 2004, 130:1100-1103.
12. Holsinger FC, Weber RS: Swing of surgical pendulum: a return to surgery for treatment of head-and-neck cancer in 21st century? Int J Radiat Oncol Biol Phys 2007, 69(Suppl): S129-S131
13. Strong MS, Jako GJ: Laser surgery in the larynx: early clinical experience with continuous CO2 laser. Ann Otol Rhinol Laryngol 1972, 81:791-798.
14. Steiner W, Ambrosch P: Endoscopic Laser Surgery of the Upper Aerodigestive Tract with Special Emphasis on Cancer Surgery. Translated by Knappe MV. Stuttgart, Germany; New York, NY: Georg Thieme Verlag; 2000.
15. Hockstein NG, Nolan JP, O'Malley BW, Jr, et al.: Robotic microlaryngeal surgery: a technical feasibility study using the daVinci surgical robot and an airway mannequin. Laryngoscope 2005, 115:780-785.
16. Weinstein GS, O'Malley BW, Jr. Snyder W, et al.: Transoral robotic surgery: supraglottic partial laryngectomy. Ann Otol Rhinol Laryngol 2007, 116:19-23.
17. McWhorter AJ, Hoffman HT: Transoral laser microsurgery for laryngeal malignancies. Curr Probl Cancer 2005, 29:180-189.
18. Pearson BW, Salassa JR: Transoral laser microresection for cancer of the larynx involving the anterior commissure. Laryngoscope 2003, 113:1104-1112.
19. Steiner W, Martin A, Ambrosch P, et al.: Laser microsurgica] treatment of pT2/#N0 carcinoma of the glottis: results of 301 cases. Presented at the 85th Annual Meeting of the American Broncho-Esophageal Association. May 14, 2005; Boca Raton, FL.
20. Hinni ML, Salassa JR, Grant DG, et al.: Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007, 133:1198-1204.
21. Iro H, Waldfahrer F, Attendorf-Hofmann A, et al.: Transoral laser surgery of supraglottic cancer. Arch Otolaryngol Head Neck Surg 1998, 124:1245-1250.
22. Davis RK, Kriskovich MD, Galloway EB III, et al.: Endoscopic supraglottic laryngectomy with postoperative irradiation. Ann Otol Rhinol Laryngol 2004, 113:132-138.
23. Zeitels SM, Hillman RE, Franco RA, Bunting GW: Voice and treatment outcome for phonosurgical management of early glottic cancer. Ann Otol Rhinol Laryngol 2002, 190(Suppl):3-20.
24. Weinstein GS, Laccourreye O, Brasnu D, Laccourreye H: Organ Preservation Surgery for Laryngeal Cancer. San Diego. CA: Singular; 2000.
25. Holsinger FC, Laccourreye O, Weinstein GS, et al.: Technical refinements in the supracricoid partial laryngectomy to optimize functional outcomes. J Am Coll Surg 2005, 201:809-820.
26. Chevalier D, Laccourreye O, Brasnu D, et al.: Cricohyoido-epiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol 1997, 106:364-369.
27. Dufour X, Hans S, De Mones E, et al.: Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3. Arch Otolaryngol Head Neck Surg 2004, 130:1092-1099.
28. Naudo P, Laccourreye O, Weinstein G, et al.: Functional outcome and prognosis factors after supracricoid partial laryngectomy with cricohyoidopexy. Ann Otol Rhinol Laryngol 1997, 106:291-296.
29. Laccourreye O, Weinstein G, Naudo P, et al.: Supracricoid partial laryngectomy after failed laryngeal radiation therapy. Laryngoscope 1996, 106:495-498.
30. Mendenhall WM, Amdur RJ, Palta JR: Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol 2006, 24:2618-2623.
31. Chao KS, Ozyigit G, Tran BN, et al.: Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003, 55:312-321.
32. Lee N, Xia P, Fischbein NJ, et al.: Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 2003, 57:49-60.
33. Yao M, Dornfeld KJ, Buatti JM, et al.: Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma - the University of Iowa experience. Int J Radiat Oncol Biol Phys 2005, 63:410-421.
34. Grandis JR, Melhem MF, Barnes EL, Tweardy DJ: Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 1996, 78:1304-1292.
35. Ang KK, Berkey BA, Tu X, et al.: Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 2002, 62:7350-7356.
36. Bonner JA, Harari PM, Giralt J, et al.: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006, 354:567-578.
37. Bonner J, Harari P, Giralt J, et al.: Improved preservation of larynx with the addition of cetuximab to radiation for cancers of the larynx and hypopharynx [abstract]. J Clin Oncol 2005, 23(16S):abstract 5533.
38. Rogers SN, Gwanne S, Lowe D, et al.: The addition of mood and anxiety domains to the University of Washington quality of life scale. Head Neck 2002, 24:521-529.
39. Cella DF: Manual for the Functional Assessment of Cancer Therapy (FACT) Measurement System (v.3). Chicago, IL: Rush Medical Center; 1994.
40. Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al.: Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 1999, 17:1008-1019.
41. List MA, D'Antonio LL, Cella DF, et al.: The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. Cancer 1996, 77:2294-2301.
42. Chen AY, Frankowski R, Bishop-Leone J, et al.: The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M.D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001, 127:870-876.